What s New in Menopause Management. Objectives
|
|
- Mildred Wheeler
- 6 years ago
- Views:
Transcription
1 What s New in Menopause Management Leslee L. Subak, MD Professor of Obstetrics, Gynecology & Reproductive Science University of California, San Francisco Objectives Define the menopause transition Review menopausal symptoms Evidence-based treatments for vasomotor and vaginal symptoms How to use and stop using hormone therapy
2 Stages of Reproductive Aging Age: young ~45-50 yo ~ >50 yo Stage: Reproductive Menopause Transition Postmenopause regular cycles irregular/missed cycles no menses >12 mo regular ovulation intermittent anovulation anovulation fertile less fertile infertile E pg/ml same or maybe higher 0-15 pg/ml T 400 pg/ml same same FSH 10 miu/ml same or higher >100 miu/ml LH 10 miu/ml same or higher >100 miu/ml Soules, NIH Consensus Conference, Fertil Steril, 2001 Definitions Perimenopause - several years before and 1 year after menopause Early menopause transition Late menopause transition Menopause cessation of menstruation End of ovulation and cyclic bleeding End of fertility and need for birth control Positive experience for many women Marker of aging
3 What Happens at Menopause? Cessation of menses end cyclic bleeding end of ovulation and fertility marked (retrospectively ) by final menstrual period Changes in hormones estrogen, progesterone, FSH, LH, GnRh Positive experience for many women Aging What Symptoms are Related to Menopause? Many reported by middle-aged women Few associated with menopause transition Hot flushes and night sweats Vaginal dryness that can cause dyspareunia Trouble sleeping Depressive symptoms Other common symptoms may be related to aging, stress, other symptoms Nelson, Evidence Report #120, 2005
4 Problems Peri-Postmenopause Abnormal uterine bleeding Vasomotor symptoms Genital atrophy Decrease in skin collagen Rapid bone loss Increase in coronary heart disease Increase in Alzheimer s disease
5 Prevalence and Risks Factors for Hot Flushes % of women Hot Flushes* Risk Factors Surgical menopause African-American, Latina Higher BMI Cigarette smoking *Gold, Am J Epidemiol, 2000 Randolph, J Clin Endocrinol Metab, 2004 Etiology of Hot Flushes Thermoregulation in Women without Hot Flushes Thermoregulation controlled by anterior hypothalamus and local vascular factors Core body temperature (CBT) above threshold results in vasodilation, sweating and heat release Thermoregulatory null zone CBT below threshold results in vasoconstriction, shivering and heat conservation and production Thermoregulation in Women with Hot Flushes Altered thermoregulation CBT at which women with hot flushes vasodilate and sweat is 0.3 degrees C lower Narrowed thermoregulatory null zone than premenopausal women or women without flushes.
6 Etiology of Hot Flushes Hot flush is a heat release mechanism But occurs at normal core body temp Not simply estrogen deficiency E 2 in women with and without flushes similar other women with low, high or variable estrogen levels do not flush Abnormality of hypothalamus related to CNS adrenergic or serotonergic neurotransmission? CNS opioids peripheral vascular instability Evaluation of Hot Flushes History crucial Age (mean age 52; 50 in smokers; range 45-60) Menstrual history (shorter, longer or missed cycles) Physical exam none needed Laboratory tests generally none needed FSH > 30pg/ml confirmatory But FSH often normal in early menopause transition
7 Diagnosis of Hot Flushes Usually clear from history Differential diagnosis Alcohol consumption Carcinoid Dumping syndrome Hyperthyroidism Narcotic withdrawal Pheochromocytoma Medications - nitrates, niacin, gonadotropinreleasing hormone agonists, antiestrogens Estrogen Relieves Hot Flushes in Hot Flushes Placebo conjugated estrogens mg plus alone MPA (cyc) MPA (cont) P (cyc) Greendale (PEPI), Obst Gynecol 1998
8 Treatment of Hot Flushes Estrogen Daily Dose % in HF 1 Oral CEE Oral E TD E Estrogen effective - All preparations - Any route - Dose dependent Placebo % reduction 1 Utian, Fertil Steril, 2001; 2 Notelovitz, Obstet Gynecol, 2000; 3 Utain, Am J Obst Gyn, 1999; 4 Bachmann, Obstet Gynecol, 2007 Side Effects of Estrogen Treatment Breast tenderness Endometrial hyperplasia Headache Bleeding Percent increase in risk of uterine cancer Years of Estrogen Use *Grady, Obstet Gynecol, 1995
9 Progestin Must be Added to Estrogen to Prevent Endometrial Cancer Any progestin effective Oral, transdermal, or vaginal route Preparations medroxyprogesterone acetate norethindrone micronized progesterone Side effects More breast tenderness Uterine Bleeding Probable increased risk of adverse events Approaches to Adding Progestin Cyclic/sequential Estrogen given every day Progestin added 10 or 14 days/mo (or Q 3-4 mo) Causes cyclic, menstrual-like bleeding Continuous/daily Estrogen given every day Progestin given at ½ dose every day Causes erratic bleeding in the first 6 to 12 months of use; subsequently amenorrhea Side effects - more breast tenderness, bleeding, probable increased risk of events Estrogen and progestin can be given separately or as combination preparation
10 Estrogen: Newer Regimens and Preparations Lower doses CE - 0.3, 0.45mg E mg New routes of delivery vaginal rings (Estring, Femring) skin gels (EstroGel) TD E , 0.025mg Use lowest dose of estrogen adequate to control symptoms Dose of progestin related to estrogen * See handout Newer Regimens and Preparations Long cycle progestin use 14 days every 3 to 6 months Vaginal gel (Prochieve) New combination pills and patches * See handout
11 Bioidentical Hormones Hormones identical to endogenous Often = pharmacy compounding 17β-estradiol, "plant-derived, natural, Goal: targeted level of hormones in the body Limited evaluation of safety and efficacy Estrone, estradiol, progesterone (available in FDAapproved manufactured products and as pharmacycompounded products Estriol (available in Europe, not approved in US) Expected to have the same risks and benefits of comparable approved drugs Progesterone may have improved safety profile Risks and Benefits of Hormone Therapy Two decades ago, observational studies suggested that hormone therapy reduced risk fracture heart disease increased risk breast cancer If true, hormone therapy would be beneficial on balance for most women Grady, Ann Intern Med, 1992
12 The Last Decade Evidence from randomized trials Alternatives treatments for fracture prevention prevention of coronary events treatment of menopausal symptoms Women s Health Initiative Randomized Trials 2 NIH-funded concurrent randomized trials in postmenopausal women uterus - CE+MPA vs. placebo (16,606) no uterus - CE vs. placebo (10,739) Multiple outcomes Planned follow-up 9 years Both trials stopped early due to lack of benefit or harm
13 What did the WHI trials show? 1. No increased risk of breast cancer 2. No decreased risk of CHD 3. Increased risk of VTE 4. All of the above 5. It s complicated 6. The trials were worthless WHI Results Relative Risks WHI E+P 1 WHI E only 2 CHD events 1.3* 0.9 Stroke 1.4* 1.4* Pulmonary embolism 2.1* 1.3 Breast cancer 1.3* 0.8 Colon cancer 0.6* 1.0 Hip Fracture 0.7* 0.6* Death Rossouw, JAMA, WHI Steering Committee, JAMA 2004 *p-value <.05
14 Adverse Effects of Hormone Therapy Risk per 1000/year Harm E+P 1 Estrogen 2 CHD + 0.7* - Stroke + 0.8* +1.2* Breast cancer + 0.8* - Pulm. embolus + 0.8* Benefit Hip fracture - 0.5* -0.6* Colorectal cancer -0.6* - Net bad events +2.0* Rossouw, JAMA, WHI Steering Committee, JAMA 2004 * p <.05 Endocrine Society 2010
15 Net Effect of Hormone Therapy is Harm Risk is Small for Short-term Use No role for prevention Estrogen only 0.6/1000 bad outcomes each year 3/1000 or 1/300 for 5 years of treatment Estrogen plus progestin 2/1000 bad outcomes each year 10/1000 or 1/100 for 5 years of treatment Timing hypothesis Possibly no increased CHD risk among women within 10 years of menopause 1 But other harms still present 2 1 Rossouw, JAMA, Prentice, Am J Epidemiol, 2009 Hormone related indicators of the risk of breast cancer ASRM Practice Committee Report 2008
16 Applying Risks from WHI to Symptomatic Women Women in WHI averaged 63 years old Women with menopausal symptoms generally 45 to 55 Disease rates lower in younger women Relative risks have less impact Estimated Risks of Hormone Therapy in Symptomatic Women Assume treating women in early 50s Unopposed estrogen.8/10,000 per year of treatment* 4/10,000 or 1/2500 for 5 years Estrogen plus progestin 1.6/1000 per year of treatment* 8/1000 or 1/150 for 5 years Risks are small for individual woman, but major public health impact if millions of users *Grady, NEJM, 2006
17 Prevention of Osteoporotic Fractures Harms seen in WHI clearly apply Women in WHI averaged 63 years old Women treated to prevent osteoporotic fractures are generally older Long-term treatment is required Estrogen should not be first-line therapy Prefer bisphosphonates or other drugs unless contraindications Hormone Therapy for Hot Flushes Given net effect of hormone therapy is harm and purpose is to control symptoms Use lowest dose that controls symptoms* Stop therapy when symptoms resolve* Contraindications Breast cancer or high risk of breast cancer Deep vein thrombosis or high risk Transdermal estrogen probably safer Active liver or gallbladder disease *FDA; American College of Obstetrics and Gynecology; North American Menopause Society
18 Symptomatic Treatment Given that net effect of hormone therapy is harm, treatment should be lowest dose of Estrogen and Progestin TD E mg/d Standard dose Q3-4 mo oral E mg - MPA 5mg x 14 d CEE mg - MPA 10mg x 10 d - progesterone 200mg x 14 d - shortest time possible FDA; American College of Obstetrics and Gynecology; North American Menopause Society How long do hot flushes last? 1. A few months 2. A few years 3. Average of 8 years 4. Average of 15 years
19 Natural History of Hot Flushes In many women, resolve in a few years Mean duration 8 years In 10-15%, persist into late life Course variable, unpredictable Hormones for Hot Flashes Estrogen +/- progestin very effective most women with hot flashes are young hot flashes usually resolve in a few years Risk of bad outcomes is small, especially with unopposed estrogen
20 Endocrine Society 2010 Stopping Hormone Therapy Determine if symptoms have resolved Stop therapy every 6 months to 1 year If bothersome symptoms, recur resume After 5 years or so on therapy, if still symptomatic, attempt taper Dose taper Day taper For severe symptoms, long-term continuation of HT is reasonable
21 Hot Flushes: Alternatives to Estrogen Lifestyle Changes Lower ambient temperature* Dress in layers All kinds of other amazing things *Kronenberg, J Therm Biol, 1992
22 Alternative Therapies Possibly effective (pilots and small trials) Paced respiration Restorative yoga Mixed/poor evidence Acupuncture Exercise (worsened hot flashes in 1 trial) Not effective Homeopathy Magnets Herbs and Supplements Slightly effective Vitamin E 800 IU QD ( 1 HF/day) Mixed/poor evidence Black cohosh Phytoestrogens No benefit Chinese herbs (so far) Dong quai Evening primrose Ginseng Red Clover No data Chasteberry Licorice Wild yam
23 Other Hormones % Reduction Estrogens 55-95% Tibolone mg* 80-95% Megestrol 20 mg BID 75% MPA 20 mg BID 75% Placebo 30-50% * Not available in the US Other Drugs % Reduction Antidepressants 50-65% - citalopram (celexa) 30mg:1- trial - - Escitalopram (lexapro) 20 mg: 1+ trial + - Fluoxetine (prozac) 20-30mg:1+/1- trial +/- - Paroxetine (paxil) mgCR/20 mg:2 + trials ++ - Venlafaxine (effexor) mg:1+/1? trial +/- Gabapentin mg: 4+ trials 50% Clonidine mixed evidence 30% Placebo 20-50%
24 Treatment of Hot Flushes Mild symptoms Lifestyle change Tolerance Moderate symptoms Low dose estrogen+/-progestin Paroxetine or gabapentin Severe symptoms Moderate dose estrogen +/- progestin Taper and/or stop as symptoms improve Case 1 Ms. HF could try lifestyle changes or nonhormone treatment, but she likely needs hormone therapy (unless contraindicated) - Give estrogen alone if no uterus Prefer estradiol? Transdermal? - Add a progestin if she has a uterus - Lowest dose that relieves symptoms - Try stopping every 6 months
25 Menopausal Vaginal Symptoms Vaginal symptoms Dryness Itching - Discomfort - Dyspareunia Prevalence 30% in early menopause 50% in late menopause Unlike hot flushes, symptoms generally do not resolve Etiology of Vaginal Symptoms Changes in symptomatic women Epithelial cells more immature Decreased blood flow and secretions Hyalinization of collagen Fragmentation of elastin Vaginal fluid less acidic (ph > 6.0) Enteric organisms proliferate Etiology estrogen deficiency?
26 Evaluation of Vaginal Symptoms Pelvic examination Pallor, dryness, decreased rugosity of vaginal mucosa (vaginal atrophy) Rule out other causes of symptoms infection trauma Laboratory evaluation - none Treatment of Vaginal Symptoms Estrogens 80 to 100% effective Vaginal preparations preferred (HANDOUT) Provide low systemic dose of estrogen Generally few side effects Do not need added progestin* Systemic estrogen less effective Might be adequate, esp. if also needs treatment for hot flushes *Suckling, Cochrane Database Syst Rev, 2003
27 Treatment of Vaginal Symptoms Vaginal moisturizers Replens (other brands not tested) Bioadhesive polycarbophil-based As effective as estrogen vaginal cream Vaginal lubricants Astroglide, etc. Short-acting lubricants Use prior to intercourse to relieve dyspareunia *Suckling, Cochrane Database Syst Rev, 2003 Nachtigall, Fertil Steril, 1994 Case 2 Ms VA will probably get relief by using either a vaginal estrogen or a moisturizer such as Replens Estrogen cream or tablet daily for 2 weeks, then 2-3 times/week Replens 3 times/week
28 Summary Hot flushes and night sweats Treat based on severity of symptoms Hormones most effective treatment Risk for adverse events is small Use lowest effective dose Stop when symptoms resolve Vaginal symptoms Vaginal estrogen or Replens Depressive symptoms Treat as for depression
29 Case 1 Ms HF: A 51 yo lawyer with frequent hot flushes, night sweats, and trouble sleeping Symptoms are ruining her life Last menstrual period 6 months ago What would you suggest? 1. Wear layers, keep the windows open the symptoms will resolve with time 2. Estrogen (with a progestin if she has a uterus) 3. Anti-depressant 4. Gabapentin 5. More tofu in her diet
30 Case 2 Ms VA: A 60 yo photographer complaining of vaginal dryness, itching and dyspareunia Symptoms are ruining her sex life Last menstrual period age 49 What would you suggest? 1. Estrogen cream 2. Vaginal moisturizer 3. Vaginal lubricant 4. Just give it up
Venous thromboembolism 5 years of use *p-value <.05. Net bad events +2.0* +0.6
Management of Menopause: Should New Data Change Our Practice? Mary S. Beattie, MD, MAS Associate Professor of Medicine UCSF Women s Health, Primary Care Director of Clinical Research, UCSF Cancer Risk
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationOVERVIEW OF MENOPAUSE
OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause
More informationWomen s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationManagement of Menopausal Symptoms
Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of
More informationWHI Estrogen--Progestin vs. Placebo (Women with intact uterus)
HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric
More informationPrior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD
Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,
More informationMENOPAUSAL HORMONE THERAPY 2016
MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.
More informationNavigating the Change: Leading Patients Through Menopause
4:30pm - 5:30pm: Breakout 5 - Women s Health Option A: Navigating the Change: Leading Patients Through Menopause ACPE UAN 0107-0000-10-025-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based Program
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationCase Presentation. Learning Objectives. Case Presentation. Case Presentation
Learning Objectives To apply up to date information about the natural history of menopause to improve the care of individual women To counsel women about the risks and benefits of systemic hormone therapy
More informationVirtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11
Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11 Clinical Pearl Post Women's Health Initiative Menopausal Women and Hormone Therapy by JoAnn V. Pinkerton,
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG Consultant Gynaecologist Heart of England NHS Foundation Trust rajsaha1@yahoo.co.uk Content of today s talk Aims
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationMenopause & HRT. Rosie & Alex. Image:
Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway
More informationAppendix: Reference Table of HT Brand Names
Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationManagement of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit
Management of Menopausal Symptoms in Patients with Breast Cancer Mike Dixon Edinburgh Breast Unit Menopausal symptoms have a major impact on Quality of Life Variety of Symptoms associated with the Menopause
More informationLessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice
Lessons from the WHI HT Trials: Evolving Data that Changed Clinical Practice JoAnn E. Manson, MD, DrPH, FACP Chief, Division of Preventive Medicine Interim Executive Director, Connors Center Brigham and
More informationMenopause and HRT. John Smiddy and Alistair Ledsam
Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation
More informationWhat is the menopause?
Information for you Alternatives to hormone replacement therapy for symptoms of the menopause Published in December 2011 This information is for you if you are considering alternatives to hormone replacement
More informationWhat's New in Menopause Management
Annual Review of Family Medicine December 10, 2015 San Francisco, CA What's New in Menopause Management Michael Policar, MD, MPH Clinical Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationOrals,Transdermals, and Other Estrogens in the Perimenopause
Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter
More informationMenopause and Post Gynecological Reproductive Care
Menopause and Post Gynecological Reproductive Care Nguyet-Cam Vu Lam, MD, FAAFP Associate Program Director St. Luke s Family Medicine Residency 1 Disclosure Dr. Nguyet-Cam Vu Lam has no conflict of interest,
More informationManagement of Perimenopausal symptoms
Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationFlashpoint: Regulating Your Body s Temperature. Presented by: Shari M. Lawson, MD MBA Date Presented: November 1,
Flashpoint: Regulating Your Body s Temperature Presented by: Shari M. Lawson, MD MBA Date Presented: November 1, 2014 1 Disclosures None 2 Objectives Today s discussion will cover How body temperature
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationApplying Best Evidence to Menopause Management MENOPAUSE IS NOT A DISEASE. Overview. Feminine Forever. Page 1
Applying Best Evidence to Menopause Management Judith Walsh, MD, MPH Division of General Internal Medicine Women s Health Center of Excellence UCSF Overview Natural history of menopause Hormone therapy:
More information22/09/2014. Menopause Management. Menopause. Menopause symptoms
Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):
More informationMenopause - a summary of management
Page 1 of 5 Menopause - a summary of management Original article by: May Su Resources Menopause treatment algorithm The Jean Hales Foundation for women's heath. Menopause, a treatment algorithm. (Australian
More informationGuidelines for Menopause Management
Guidelines for Menopause Management Judith M.E. Walsh, MD, MPH Professor of Medicine UCSF Women s Health Center of Excellence Conflicts of Interest: None Overview Natural history of menopause Hormone therapy:
More informationMenopause & HRT. Matt McKenna Elliot Davis
Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea
More informationHRT. Responding to questions about. The Women s Health Initiative (WHI) is a large, CME Workshop. associated with combined
CME Workshop Responding to questions about HRT By Margaret Burnett, MD, BA(Hon), MA, CCFP, FRCPC The Women s Health Initiative (WHI) is a large, prospective, placebo-controlled trial sponsored by the National
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More informationBy J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University
By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University Cessation of menstruation as a result of the aging process of or surgical removal of the ovaries; change
More informationAusPharm CE Hormone therapy 23/09/10. Hormone therapy
Hormone therapy Learning objectives: Assess options to address quality of life and health concerns of menopausal women Outline indications for hormone therapy Counsel women on the risks and benefits of
More informationMenopause Matters. Equity Office Staff Seminar 14 November 2018
Menopause Matters Equity Office Staff Seminar 14 November 2018 1 What to expect at menopause How to manage symptoms Support at work Dr Janice Brown Medical lead, The University of Auckland NZ representative,
More informationThis includes bone loss, endometrial cancer, and vasomotor symptoms.
Hello and welcome. My name is Chad Barnett. I m a Clinical Pharmacy Specialist in the Division of Pharmacy at the University of Texas, MD Anderson Cancer Center and I m very pleased today to be able to
More information11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause
Update on HRT Miss Moneli Golara Consultant Obstetrician and Gynaecologist MBBS, FRCOG Highgate Private Hospital (Barnet Hospital) E: lauren@medicaladministration.co.uk Women s Health Life expectancy of
More informationApplying Best Evidence to Menopause Management
Applying Best Evidence to Menopause Management Judith Walsh, MD, MPH Division of General Internal Medicine Women s Health Center of Excellence UCSF Overview Natural history of menopause Hormone therapy:
More informationMenopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time.
Menopause and HIV Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Menopause? Menopause: Point in time when a woman's menstrual periods
More informationBioIdentical Hormone Replacement Therapy for Women
BioIdentical Hormone Replacement Therapy for Women Bio-Identical Hormones are manufactured hormone products from soy or yam. They are changed in a laboratory so that the hormones produced are identical
More informationNorth American Menopause Society (NAMS)
North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationCASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology
CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology A 49-year-old woman complains of irregular menses over the past 6 months, feelings of inadequacy, vaginal dryness, difficulty sleeping, and episodes
More informationPrimary Care of the Breast Cancer Survivor. Case Presentation. Case Presentation (cont) Case Presentation (cont) Breast Cancer
Primary Care of the Breast Cancer Survivor Janet P. Pregler, MD Professor of Clinical Medicine Director, Iris Cantor UCLA Women s Health Center Case Presentation B.C. is a 58 year-old African American
More informationEstrogen and progestogen therapy in postmenopausal women
Estrogen and progestogen therapy in postmenopausal women The Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Hormone
More informationHRT & Menopause Where Do We Stand Now?
HRT & Menopause Where Do We Stand Now? Mrs. SY Hussain Consultant Gynaecologist The Holly Private Hospital Spire Roding Hospital The Wellington Hospital Discussion Points Discuss Recommendations made by
More informationMenopause Symptoms and Management: After Breast Cancer
Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a
More informationMenopause management NICE Implementation
Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not
More informationEstrogen (conjugated estrogens & ethinyl estradiol) Addition to the List
Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and
More informationApplying Best Evidence to Menopause Management MENOPAUSE IS NOT A DISEASE. Overview. Feminine Forever. Page 1
Applying Best Evidence to Menopause Management Judith Walsh, MD, MPH Division of General Internal Medicine Women s Health Center of Excellence UCSF Overview Natural history of menopause Hormone therapy:
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationHormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare
Hormones friend or foe? Undertreatment and quality of life Anette Tønnes Pedersen MD, Ph.D. Consultant, Associate professor Dept. Of Gynecology / Fertility Clinic Rigshospitalet No conflicts of interest
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Predicting the menopause The menopause marks the end of ovarian follicular activity and is said to have occurred after 12 months amenorrhoea. The average age of the menopause is between 45 and 60 years
More informationHT: Where do we stand after WHI?
HT: Where do we stand after WHI? Hormone therapy and cardiovascular disease risk Experimental and clinical evidence indicate that hormone therapy (HT) reduces the risk of cardiovascular disease (CVD) Women
More informationLET S START WITH (AND REMEMBER WE ARE TALKING ABOUT LOCAL E2) THERAPUTIC AGENTS: ARE THEY SAFE? Systemic HT/ET. Ospemifene. Local Estrogen Therapy
THERAPUTIC AGENTS: ARE THEY SAFE? Steven R. Goldstein, M.D. Professor of Obstetrics & Gynecology New York University School of Medicine Director of Gynecologic Ultrasound Co-Director of Bone Densitometry
More informationSERMS, Hormone Therapy and Calcitonin
SERMS, Hormone Therapy and Calcitonin Tiffany Kim, MD Clinical Fellow VA Advanced Women s Health UCSF Endocrinology and Metabolism I have nothing to disclose Thanks to Clifford Rosen and Steven Cummings
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationOverview: Identifying Candidates and Tailoring Treatment. Disclosures 10/6/2014. Vasomotor Symptoms. VMS in Postmenopausal Women
Overview: Identifying Candidates and Tailoring Treatment Risa Kagan, MD, FACOG, CCD, NCMP Clinical Professor, Department of Ob-Gyn, UCSF East Bay Physicians Medical Group Sutter Foundation, Berkeley, CA
More informationMenopause: diagnosis and management NICE guideline NG23. Published November 2015
Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published
More informationPotential dangers of hormone replacement therapy in women at high risk
ESC meeting, Stockholm, August 30, 16.30-18.00, 2010 Potential dangers of hormone replacement therapy in women at high risk Karin Schenck-Gustafsson MD, PhD, FESC Professor, Chief consultant Department
More informationNon hormonal medical treatment of vasomotor symptoms
Non hormonal medical treatment of vasomotor symptoms Caroline Antoine Menopause Clinic Department of Gynaecology and Obstetrics CHU Saint-Pierre Belgian Menopause Society Symposium November 14, 2015 No
More informationMenopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationPearls for Menopause Management: I m ready: now what?
Pearls for Menopause Management: I m ready: now what? Friday November 13, 2015 Susan Goldstein MD CCFP FCFP NCMP Assistant Professor Department of Family and Community Medicine University of Toronto Menarche
More informationPharmacology Update: Menopause and Hormone Therapy North American Menopause Society Meeting Disclosure
Pharmacology Update: Menopause and Hormone Therapy North American Menopause Society Meeting 2015 Disclosure The faculty and planners for this activity, as well as the CME staff, do not have any relevant
More informationOutline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013
Outline Estrogens and SERMS The forgotten few! Clifford J Rosen MD rosenc@mmc.org Physiology of Estrogen and estrogen receptors Actions of estrogen on bone BMD, fracture, other off target effects Cohort
More informationMs. Y. Outline. Updates of SERMs and Estrogen
Ms. Y Updates of SERMs and Estrogen Steven R. Cummings, MD, FACP San Francisco Coordinating Center CPMC Research Institute and UCSF Support from Lilly, Pfizer, Berlex 55 y.o. woman with mild hypertension
More informationNew Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group
New Treatments for Vaginal Health There s Hope Sarah Azad, MD El Camino Women s Medical Group The Genitrourinary Syndrome of Menopause (GSM) Problems with genital health secondary to the changes that occur
More informationBefore you prescribe
Initiating hormone replacement therapy (HRT) / menopausal hormone therapy (MHT) Dr Sonia Davison Jean Hailes Consultant Endocrinologist Before you prescribe Ensure there are no contraindications to HRT/MHT
More informationWHI Form 55 Estrogen-Alone Survey Ver. 2
Date Received: - - (M/D/Y) Reviewed By: - Affix label here- Clinical Center/ID: - - First Name M.I. Last Name Contact Type: Phone Visit Type: Form Administration: Mail Semi-Annual # Self 3 Visit 3 Annual
More informationAcne rosacea is a skin condition that causes facial flushing and can co-exist with menopausal flushing.
MANAGING HOT FLUSHES In Western societies, the most common menopause symptom is the hot flush. This typically begins as a feeling of heat in the chest or upper body which then spreads all over the body,
More informationPostmenopausal hormone therapy - cardiac disease risks and benefits
Postmenopausal hormone therapy - cardiac disease risks and benefits Tomi S. Mikkola, MD Helsinki University Central Hospital Department of Obstetrics and Gynecology Helsinki, Finland Disclosures Speaker/consulting
More informationThis information can be found by going to Hot Flashes
Winsor Pilates - Official Site Reach physical and mental health while sculpting your... www.winsorpilates.com ML Speakers Group -Women's Health Today Book an exciting speaker to make your event special.
More informationHormone therapy. Where are we now? Menopause. Menopause symptoms. Background. Objective. Discussion. Keywords: menopause; hormone therapy
Menopause Helena J Teede Amanda Vincent Hormone therapy Where are we now? Background Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity. The characteristic
More informationHORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer
HORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer -- PART 1 -- Definitions HRT hormone replacement therapy HT genome therapy ERT estrogen replacement therapy ET estrogen EPT estrogen progesterone therapy
More informationMENOPAUSE IS NOT A DISEASE
Clinical Dilemmas in Menopause Management: A Case Based Approach Judith M.E. Walsh, MD, MPH Professor of Medicine UCSF Women s Health Center of Excellence Conflicts of Interest: None Overview Natural history
More informationDepartment of Obstetrics and Gynecology, Osaka Medical College, Takatsuki-city, Osaka , Japan. Pituitary gonadotropin, Clinical managament
Original Article Adequate Reduction Degree of Pituitary Gonadotropin Level in the Clinical Management of Short-Term Hormone Replacement Therapy of Women with Menopausal Symptoms Department of Obstetrics
More informationThe Good, The Bad, and The Ugly of Hormonal Therapy, Trastuzumab and Docetaxel
The Good, The Bad, and The Ugly of Hormonal Therapy, Trastuzumab and Docetaxel Diane Johnson Pharmacist, CCMB June 6 th, 2015 Presenter Disclosure Speaker: Diane Johnson Relationships with commercial interests:
More informationDisclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None
Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease Micol S. Rothman, MD Associate Professor of Medicine Endocrinology, Diabetes and Metabolism Clinical Director Metabolic Bone
More informationQuality of Life. Local Therapy of UG Atrophy. Key Message #1 24/05/2018. Perception of Fears/Problems at Menopause
Disclosure Menopause Webinar May 24, 2018 Gillian Graves Obs Gyn Dalhousie University Retired No Advisory Boards or other industry relations Guidelines Oversight Committee SOGC Royal College Subspecialty
More informationThe Estrogen Question
The Estrogen Question Hormone Therapy still offers the best relief for menopausal symptoms. Is it right for you? When 49-year-old Lee Ann Dodson heard the news that the Women's Health Initiative (WHI)
More informationPractical recommendations for hormone replacement therapy in the peri- and postmenopause
CLIMACTERIC 2004;7:in press Practical recommendations for hormone replacement therapy in the peri- and postmenopause Recommendations from an Expert Workshop, February 2004 Henry Burger, Australia; David
More informationTreatment of Mood Disorders in Midlife Women
Treatment of Mood Disorders in Women KAY ROUSSOS-ROSS, MD UNIVERSITY OF FLORIDA DEPARTMENTS OF OBGYN AND PSYCHIATRY Disclosures I HAVE NO DISCLOSURES Objectives UNDERSTAND INCIDENCE OF MOOD DISORDERS IN
More informationDisclosures. Objec7ves 9/9/15. What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC.
What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC Disclosures None Objec7ves Discuss terminology of bio- iden7cal, synthe7c and natural hormones.
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationDeciding whether or not to use Hormone Therapy (HT) is a big decision and should be
Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize
More information5. Summary of Data Reported and Evaluation
326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal
More informationGary Elkins, PhD., ABPP
Gary Elkins, PhD., ABPP *What are Hot Flashes? *Hormone Replacement Therapy *Alternate Treatment Options *Clinical Hypnosis? *Methods *Preliminary Results *Conclusions & Future Directions *Over 66% of
More informationHormone therapy for menopausal vasomotor symptoms
Hormone therapy for menopausal vasomotor symptoms Given our available (better) options for treating hot flashes, can we reduce our use of medroxyprogesterone acetate? OBG Manag. 2014;26(7):10,13 15. Robert
More informationHOW TO MAKE SENSE OF MENOPAUSE. by Steven. F. Hotze, M.D.
HOW TO MAKE SENSE OF MENOPAUSE by Steven. F. Hotze, M.D. INTRODUCTION Dr. Hotze is founder of Hotze Health & Wellness Center and author of the book Hormones, Health, and Happiness. He has enabled thousands
More informationBenton Franklin County Medical Society 31st Annual CME Seminar
Management of Current HT/ET and SERM Recommendations Benton Franklin County Medical Society 31st Annual CME Seminar February 21, 2015 Kennewick, Washington Spokane steoporosis Dr. Lynn Kohlmeier Lynn Kohlmeier,
More informationAPPROACH TO THE MENOPAUSAL PATIENT & CURRENT MANAGEMENT of Menopausal Symptoms
APPROACH TO THE MENOPAUSAL PATIENT & CURRENT MANAGEMENT of Menopausal Symptoms MOA AUTUMN CONFERENCE NOVEMBER 17, 2018 DAVID J BOES, DO, FACOOG BOES@MSU.EDU 1 DISCLOSURES NOTHING TO DISCLOSE RELATIVE TO
More informationBioidentical Hormones
2014 Bioidentical Hormones Bioidentical Hormones for Menopause-related Vasomotor Symptoms What are menopause-related vasomotor symptoms? Menopause is defined as not menstruating (having your period) for
More informationManagement of Menopausal Symptoms
Clinical Expert Series Management of Menopausal Symptoms Andrew M. Kaunitz, MD, and JoAnn E. Manson, MD, DrPH Downloaded from https://journals.lww.com/greenjournal by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3K8IvHCABgh/bIG0s8pUeOW5ZlL84rYIWpMvpbO4KRoE=
More informationDINE AND LEARN ENDOCRINOLOGY PEARLS. Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC
DINE AND LEARN ENDOCRINOLOGY PEARLS Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC OUTLINE HRT and CVD HRT and Breast Cancer Osteoporosis When to treat How long to treat for Bisphosphonates BMD
More information